Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04250246 |
| Title | A Study of NIVO Plus IPI and Guadecitabine or NIVO Plus IPI in Melanoma and NSCLC Resistant to Anti-PD1/PDL1 (NIBIT-ML1) |
| Acronym | NIBIT-ML1 |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Italian Network for Tumor Biotherapy Foundation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Center for Immuno-Oncology, University Hospital of Siena | Siena | 53100 | Italy | Details |